Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Bioclone Australia Pty , Ltd. — Predicate Candidate Screening

10 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

36 daysmedian FDA review time
348 days90th percentile
10clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K935049ELEGANCE NEONATAL TSH ELISABioclone Australia Pty , Ltd.1994-10-033480
K922284ELEGANCE FT4 ELISABioclone Australia Pty , Ltd.1992-07-10560
K910419BIOCLONE'S ELEGANCE IGE ELISA KITBioclone Australia Pty , Ltd.1991-06-211420
K910420BIOCLONE'S ELEGANCE HCG ELISA KITBioclone Australia Pty , Ltd.1991-02-26270
K905099ELEGANCE TSH ELISABioclone Australia Pty , Ltd.1990-12-18350
K905098ELEGANCE GH ELISABioclone Australia Pty , Ltd.1990-12-06230
K904822ELEGANCE FERRITIN ELISABioclone Australia Pty , Ltd.1990-11-29360
K904387BIOCLONES ELEGANCE LH ELISA KITBioclone Australia Pty , Ltd.1990-11-06420
K904483ELEGANCE PROLACTIN ELISABioclone Australia Pty , Ltd.1990-11-05340
K904405BIOCLONES ELEGANCE FSH ELISA KITBioclone Australia Pty , Ltd.1990-10-26310

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda